FDA Inspection
PolyPeptide Laboratories, Inc.PolyPeptide Laboratories, Inc. – FDA Inspection, Jul 19, 2017
Record Details
This FDA Inspection record concerns PolyPeptide Laboratories, Inc., with an inspection on July 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Kathy Chiu (Issuing Officer)
- Kenneth H. Williams
- Nicholas L. Hunt (FDA Associated Person)
- Santiago Gallardo Johnson (FDA Associated Person)
View Company Profile
ID · bb82abf9-badf-4502-823c-de13bd77dffb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1021060
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of PolyPeptide Laboratories, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2024 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 19, 2021 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| August 30, 2019 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 3, 2015 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 12, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for PolyPeptide Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.